01 61F. Hoffmann-La Roche
02 3Genentech
03 2ORIFARM GROUP AS
04 1Roche Products (Pty) Ltd
05 8Roche Diagnostics GmbH
01 7Concentrate For Infusion Solution
02 4Concentrate For Solution For Infusion
03 4Concentrate for infusion solution, solution
04 2INF
05 1INJECTABLE; INJECTION
06 2INJECTABLE;INJECTION
07 3Injectable Solution
08 3SOLUTION
09 1Solution for injection
10 48Blank
01 3Allowed
02 3Approved
03 8Authorized
04 2Originator
05 1Prescription
06 2Schedule D
07 56Blank
01 4TECENTRIQ
02 1TECENTRIQ 1 200 MG
03 1TECENTRIQ 840 MG
04 1TECENTRIQ HYBREZA
05 1TECENTRIQ SC
06 1TECENTRIQ subcutaneous
07 48Tecentriq
08 18Tecentriq SC
01 48Australia
02 3Canada
03 5Norway
04 2South Africa
05 8Spain
06 3Sweden
07 3Switzerland
08 3USA
Regulatory Info :
Registration Country : Norway
Brand Name : Tecentriq
Dosage Form : Concentrate for infusion solution, solution
Dosage Strength : 1,200 mg
Packaging : Vials 1 20ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Tecentriq
Dosage Form : Solution for injection
Dosage Strength : 1,875 mg
Packaging : Vials 1 15ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Tecentriq
Dosage Form : Concentrate for infusion solution, solution
Dosage Strength : 840 mg
Packaging : Vials 1 14ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Tecentriq
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 1200mg
Packaging :
Approval Date : 21/09/2017
Application Number : 20160430000118
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Tecentriq
Dosage Form : Injectable Solution
Dosage Strength : 1875mg
Packaging :
Approval Date : 18/01/2024
Application Number : 20221116000072
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Tecentriq
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 840mg
Packaging :
Approval Date : 26/08/2019
Application Number : 20180914000090
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Tecentriq
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 1200mg/20ml
Packaging :
Approval Date : 23/05/2017
Application Number : 66152
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Tecentriq
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 840mg/14ml
Packaging :
Approval Date : 23/05/2017
Application Number : 66152
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : TECENTRIQ subcutaneous
Dosage Form : Injectable Solution
Dosage Strength : 1875mg/15ml
Packaging :
Approval Date : 05/08/2024
Application Number : 69262
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : TECENTRIQ
Dosage Form : SOLUTION
Dosage Strength : 1200MG/20ML
Packaging : 20ML
Approval Date :
Application Number : 2462990
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : TECENTRIQ
Dosage Form : SOLUTION
Dosage Strength : 840MG/14ML
Packaging :
Approval Date :
Application Number : 2492393
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : TECENTRIQ SC
Dosage Form : SOLUTION
Dosage Strength : 125MG/ML
Packaging :
Approval Date :
Application Number : 2546310
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : TECENTRIQ 840 MG
Dosage Form : INF
Dosage Strength : 840mg
Packaging : 14X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info :
Registration Country : Australia
Brand Name : Tecentriq
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : USA
Brand Name : TECENTRIQ
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 1200MG/20ML
Packaging :
Approval Date :
Application Number : 761034
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : TECENTRIQ
Dosage Form : INJECTABLE; INJECTION
Dosage Strength : 1200MG/20ML
Packaging :
Approval Date :
Application Number : 761041
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
ATEZOLIZUMAB AND HYALURONIDASE-TQJS
Brand Name : TECENTRIQ HYBREZA
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 125MG;2000UNITS PER ML
Packaging :
Approval Date :
Application Number : 761347
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : Norway
Brand Name : Tecentriq
Dosage Form : Concentrate for infusion solution, solution
Dosage Strength : 840 mg
Packaging : Vials 1 14ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Tecentriq
Dosage Form : Concentrate for infusion solution, solution
Dosage Strength : 1,200 mg
Packaging : Vials 1 20ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : TECENTRIQ 1 200 MG
Dosage Form : INF
Dosage Strength : 1200mg
Packaging : 20X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
